Ultragenyx Pharmaceutical | Ventas



Sales Cambio Fecha
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
Agios Pharmaceuticals USD 10.73M 1.77M 2024-12
Alnylam Pharmaceuticals USD 593.17M 92.25M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Insmed USD 104.44M 11.02M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
Kyowa Hakko Kirin JPY 132.76B 2.94B 2024-12
MacroGenics USD 110.71M 99.91M 2024-09
Moderna USD 966M 896M 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
PTC Therapeutics USD 213.17M 16.39M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Sarepta Therapeutics USD 658.41M 191.24M 2024-12
Ultragenyx Pharmaceutical USD 164.88M 25.38M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



Ultragenyx Pharmaceutical Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.